Prediction of cardiovascular events and all-cause mortality with erectile dysfunction: a systematic review and meta-analysis of cohort studies
about
Erectile dysfunction and central obesity: an Italian perspectiveCardiovascular risk assessment in patients with diabetes.Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study.2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by represManagement of erectile dysfunction in hypertension: Tips and tricks.Men's Health Index: a pragmatic approach to stratifying and optimizing men's healthChanges in erectile dysfunction over time in relation to Framingham cardiovascular risk in the Boston Area Community Health (BACH) Survey.Erectile dysfunction as a marker for cardiovascular disease diagnosis and intervention: a cost analysis.Is erectile dysfunction a reliable indicator of general health status in men?Erectile Dysfunction in Patients with Sleep Apnea--A Nationwide Population-Based Study.Clinical and economic burden associated with cardiovascular events among patients with hyperlipidemia: a retrospective cohort studyHip Fracture in People with Erectile Dysfunction: A Nationwide Population-Based Cohort Study.Increased Risk of Dementia in Patients With Erectile Dysfunction: A Population-Based, Propensity Score-Matched, Longitudinal Follow-Up Study.Exercise prevents Western diet-associated erectile dysfunction and coronary artery endothelial dysfunction: response to acute apocynin and sepiapterin treatment.Basic Science Evidence for the Link Between Erectile Dysfunction and Cardiometabolic Dysfunction.Subclinical Vascular Disease and Subsequent Erectile Dysfunction: The Multiethnic Study of Atherosclerosis (MESA)Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality.Diabetes severity, metabolic syndrome, and the risk of erectile dysfunction.Erectile dysfunction in fit and healthy young men: psychological or pathological?Erectile dysfunction, metabolic syndrome, and cardiovascular risks: facts and controversies.Erectile dysfunction in the cardiovascular patient.The assessment of vascular risk in men with erectile dysfunction: the role of the cardiologist and general physician.How 'male health' fits into the field of urology.Pharmacologic therapy for erectile dysfunction and its interaction with the cardiovascular system.Association between pneumococcal vaccination and cardiovascular outcomes: a systematic review and meta-analysis of cohort studies.Biomarkers, erectile dysfunction, and cardiovascular risk prediction: the latest of an evolving concept.Prognostic value of exercise capacity among men undergoing pharmacologic treatment for erectile dysfunction: The FIT Project.Relationship between treatment of erectile dysfunction and future risk of cardiovascular disease: A nationwide cohort study.Atherosclerosis is associated with erectile function and lower urinary tract symptoms, especially nocturia, in middle-aged men.Aging and sexual health: getting to the problem.History of erectile dysfunction as a predictor of poor physical performance after an acute myocardial infarction.Pharmacodynamics, pharmacokinetics and clinical efficacy of phosphodiesterase-5 inhibitors.Targeting vascular (endothelial) dysfunction.Erectile dysfunction in patients with plaque psoriasis: the relation of depression and cardiovascular factors.First-generation phosphodiesterase type 5 inhibitors dropout: a comprehensive review and meta-analysis.Advances in pharmacotherapy for erectile dysfunction and associated cardiac impact.Sexual functioning mirrors overall men's health status, even irrespective of cardiovascular risk factors.Lower urinary tract symptoms/benign prostatic hypertrophy and vascular function: Role of the nitric oxide-phosphodiesterase type 5-cyclic guanosine 3',5'-monophosphate pathway.Serum testosterone, testosterone replacement therapy and all-cause mortality in men with type 2 diabetes: retrospective consideration of the impact of PDE5 inhibitors and statins.Association between treatment for erectile dysfunction and death or cardiovascular outcomes after myocardial infarction.
P2860
Q22241096-A2F6F9DD-9777-46CF-AE6A-A5DCA80D4D14Q33582582-123731A6-9702-462F-8068-0D94C0287F62Q33717374-05AA8200-F81D-42F3-870B-C901374F865AQ34046881-41085FF4-9BC8-4D52-A4CE-333553067C60Q34251875-CF8E4D03-DDE4-49DF-A9A4-9C4249BE754DQ34506843-8B014674-3BAC-4CFD-9223-BA70AC7DBA34Q35007546-D2C06D31-4097-4BD3-9E05-51AED2B99D31Q35328376-B960B03D-F57A-4D59-975D-41C415D92C4CQ35643349-C1A8F4DD-B4C2-4AE3-A753-C5A17FC65855Q35692457-54A6B9B7-F097-4A27-8092-BF4A118AD001Q35894735-AC955B73-C242-41F0-B734-B913F9965ECDQ35989863-07047A98-5A03-4895-A6CF-FA2374AF3D68Q36194578-9A5F1E78-60CC-4540-8C03-3EA8E2D96EA3Q36821633-B4B55764-C3B1-4F55-A2B9-44FB5F778FA7Q36861695-6404D724-2060-45B1-87C4-677173724D95Q36932583-288C957B-8E24-4844-A4C6-3FD4294D12B7Q37398972-D5E74EFB-85F8-4CC9-87A0-A9FF3966FBA5Q37479283-1C23B48C-27F7-4459-A4E5-B36FF7DBE01DQ37647220-79BD16D5-B812-4415-8B2D-08AA4B738E5BQ37647225-521C7307-49D8-4D46-B4AE-12CD4E5A86C0Q38101543-8A3B5756-25F4-4F72-9370-E3292A196B0CQ38109957-9D228EFF-8160-4003-AD9F-1FE8CBFF1FF9Q38125133-0867151E-EFC0-47CF-B759-BCB90C7F7125Q38166600-D6B6902F-ED12-47AC-B126-B51CD26308B2Q38253988-E616E8A8-C4BE-4336-BC7C-9796FB65B414Q38269951-D7D45B4B-A8E1-491A-BFB1-922A95A4122EQ38642909-C0368244-2744-460A-A309-F11E74AAA456Q38665739-603AB41B-6242-47B7-8ABF-81214128E113Q38737220-F386E4B0-D798-4CF1-892F-8EF7E50AA81FQ38738470-E4BD8143-506E-4BCD-A652-153AAF4A7FCDQ38773001-0A631630-7804-4EBC-B953-F6F69688A0B3Q38815890-1D780ABE-F27E-43FB-AE50-FA810E20FC95Q38836199-A451E171-7439-4AF0-B629-ACB0A8501099Q38909724-A8639EA8-10C7-4144-A608-CB48567E5729Q38956366-A6882287-9CFD-4E78-B50E-18261C39D7D9Q38966016-96378D36-0280-4001-9D88-479BB5149F09Q39091649-5D33DED1-50D2-421A-B116-6081035CC0A2Q39195242-CC14EBE1-8FFA-4EE2-A0DA-DB3CC1ADFE77Q39967508-616E63AE-715C-4F68-B3A1-43590E990A7DQ40298861-521FF399-DBC2-4545-B94E-0EC9BA713AF8
P2860
Prediction of cardiovascular events and all-cause mortality with erectile dysfunction: a systematic review and meta-analysis of cohort studies
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Prediction of cardiovascular e ...... eta-analysis of cohort studies
@ast
Prediction of cardiovascular e ...... eta-analysis of cohort studies
@en
Prediction of cardiovascular e ...... eta-analysis of cohort studies
@nl
type
label
Prediction of cardiovascular e ...... eta-analysis of cohort studies
@ast
Prediction of cardiovascular e ...... eta-analysis of cohort studies
@en
Prediction of cardiovascular e ...... eta-analysis of cohort studies
@nl
prefLabel
Prediction of cardiovascular e ...... eta-analysis of cohort studies
@ast
Prediction of cardiovascular e ...... eta-analysis of cohort studies
@en
Prediction of cardiovascular e ...... eta-analysis of cohort studies
@nl
P2093
P31
P3181
P1476
Prediction of cardiovascular e ...... eta-analysis of cohort studies
@en
P2093
Charalambos V Vlachopoulos
Christodoulos I Stefanadis
Konstantinos A Aznaouridis
Nikolaos K Ioakeimidis
P304
P3181
P356
10.1161/CIRCOUTCOMES.112.966903
P407
P577
2013-01-08T00:00:00Z